Target Validation Information | |||||
---|---|---|---|---|---|
TTD ID | T89697 | ||||
Target Name | Indoleamine 2,3-dioxygenase 1 (IDO1) | ||||
Type of Target |
Successful |
||||
Drug Potency against Target | 1,2-NAPHTHOQUINONE | Drug Info | IC50 = 7100 nM | [3] | |
1,4-Naphthoquinone | Drug Info | IC50 = 990 nM | [3] | ||
1H-indole-4,7-dione | Drug Info | Ki = 190 nM | [4] | ||
2,2-dimethyl-2H-benzo[g]chromene-5,10-dione | Drug Info | IC50 = 214 nM | [3] | ||
2,3-dichloro-1,4-naphthoquinone | Drug Info | IC50 = 280 nM | [3] | ||
2,3-dihydrobenzo[d]thiazole-2-thiol | Drug Info | IC50 = 7000 nM | [8] | ||
2,4-Dichlorobenzenemethanethiol | Drug Info | IC50 = 4600 nM | [9] | ||
2-(1H-Imidazol-4-yl)benzene-1,3-diol | Drug Info | IC50 = 5300 nM | [5] | ||
2-(1H-Imidazol-4-yl)phenol | Drug Info | Ki = 8900 nM | [5] | ||
2-Chlorobenzenemethanethiol | Drug Info | IC50 = 15000 nM | [9] | ||
2-hydroxygarveatin E | Drug Info | Ki = 1400 nM | [2] | ||
2-HYDROXYGARVIN A | Drug Info | Ki = 2300 nM | [2] | ||
2-methoxy-1,4-naphthoquinone | Drug Info | IC50 = 720 nM | [3] | ||
3,4-Dichlorobenzenemethanethiol | Drug Info | IC50 = 1100 nM | [9] | ||
3-(1H-Imidazol-4-yl)benzenethiol | Drug Info | Ki = 5300 nM | [5] | ||
3-(4H-Imidazol-4-yl)benzenethiol | Drug Info | Ki = 4800 nM | [5] | ||
4-(1H-1,2,3-triazol-5-yl)pyridine | Drug Info | IC50 = 5000 nM | [8] | ||
4-(2-(diethylamino)ethylamino)-1-naphthol | Drug Info | IC50 = 3000 nM | [8] | ||
4-(2-Hydroxyethoxy)-1-naphthol | Drug Info | IC50 = 12500 nM | [8] | ||
4-(Benzylamino)-1-naphthol | Drug Info | IC50 = 2500 nM | [8] | ||
4-(Cyclohexylamino)-1-naphthol | Drug Info | IC50 = 15000 nM | [8] | ||
4-(ethylamino)naphthalen-1-ol | Drug Info | IC50 = 16000 nM | [8] | ||
4-(Isopropylamino)-1-naphthol | Drug Info | IC50 = 12500 nM | [8] | ||
4-(methylamino)naphthalen-1-ol | Drug Info | IC50 = 12500 nM | [8] | ||
4-(Pent-3-ylamino)-1-naphthol | Drug Info | IC50 = 3500 nM | [8] | ||
4-(propylamino)naphthalen-1-ol | Drug Info | IC50 = 4500 nM | [8] | ||
4-(tert-butylamino)naphthalen-1-ol | Drug Info | IC50 = 4000 nM | [8] | ||
4-amino-1,2,5-oxadiazole-3-carboximidamide | Drug Info | IC50 = 1000 nM | [7] | ||
4-aminonaphthalen-1-ol | Drug Info | IC50 = 6000 nM | [8] | ||
4-Chlorobenzenemethanethiol | Drug Info | IC50 = 1100 nM | [9] | ||
4-Fluorobenzenemethanethiol | Drug Info | IC50 = 1900 nM | [9] | ||
4-Methoxybenzenemethanethiol | Drug Info | IC50 = 9400 nM | [9] | ||
4-methoxynaphthalen-1-amine | Drug Info | IC50 = 5500 nM | [8] | ||
4-Methylbenzenemethanethiol | Drug Info | IC50 = 6500 nM | [9] | ||
4-Phenylimidazole | Drug Info | Ki = 4400 nM | [5] | ||
4-phenylthiazole-2-thiol | Drug Info | IC50 = 4000 nM | [8] | ||
5-(isopropylamino)quinolin-8-ol | Drug Info | IC50 = 15000 nM | [8] | ||
5-aminoquinolin-8-ol | Drug Info | IC50 = 1000 nM | [8] | ||
5-phenyl-1H-1,2,3-triazole | Drug Info | IC50 = 5000 nM | [8] | ||
ANNULIN A | Drug Info | Ki = 690 nM | [2] | ||
ANNULIN B | Drug Info | Ki = 120 nM | [2] | ||
ANNULIN C | Drug Info | Ki = 140 nM | [2] | ||
Avastin+/-Tarceva | Drug Info | IC50 = 1000 nM | [3] | ||
BENZENEMETHANETHIOL | Drug Info | IC50 = 13000 nM | [9] | ||
Exiguamine A | Drug Info | Ki = 41 nM | [4] | ||
EXIGUAMINE B | Drug Info | Ki = 80 nM | [6] | ||
GARVEATIN A | Drug Info | Ki = 3200 nM | [2] | ||
Garveatin C | Drug Info | Ki = 1200 nM | [2] | ||
Garveatin E | Drug Info | Ki = 3100 nM | [2] | ||
N-[2-(Indol-3-yl)ethyl]-S-benzyl-dithiocarbamate | Drug Info | Ki = 17150 nM | [1] | ||
Naphthalene-1,4-diol | Drug Info | IC50 = 10000 nM | [8] | ||
NLG8189 | Drug Info | Ki = 6600 nM | [2] | ||
S-(2,4-Dichlorobenzyl)isothiourea hydrobromide | Drug Info | IC50 = 1100 nM | [9] | ||
S-(2-Chlorobenzyl)isothiourea hydrochloride | Drug Info | IC50 = 4800 nM | [9] | ||
S-(3,4-Dichlorobenzyl)isothiourea hydrochloride | Drug Info | IC50 = 7300 nM | [9] | ||
S-(3-Chlorobenzyl)isothiourea hydrochloride | Drug Info | IC50 = 1400 nM | [9] | ||
S-(4-Bromobenzyl)isothiourea hydrobromide | Drug Info | IC50 = 800 nM | [9] | ||
S-(4-Chlorobenzyl)isothiourea hydrochloride | Drug Info | IC50 = 600 nM | [9] | ||
S-(4-Cyanobenzyl)isothiourea hydrobromide | Drug Info | IC50 = 2600 nM | [9] | ||
S-(4-Ethylbenzyl)isothiourea hydrochloride | Drug Info | IC50 = 2500 nM | [9] | ||
S-(4-Fluorobenzyl)isothiourea hydrochloride | Drug Info | IC50 = 2000 nM | [9] | ||
S-(4-Methoxybenzyl)isothiourea hydrochloride | Drug Info | IC50 = 10000 nM | [9] | ||
S-(4-Methylbenzyl)isothiourea hydrochloride | Drug Info | IC50 = 6800 nM | [9] | ||
S-(4-Nitrobenzyl)isothiourea hydrochloride | Drug Info | IC50 = 2200 nM | [9] | ||
S-Benzyl-brassinin | Drug Info | Ki = 13220 nM | [1] | ||
Seco-exiguamine | Drug Info | Ki = 80 nM | [6] | ||
References | |||||
REF 1 | Structure-activity study of brassinin derivatives as indoleamine 2,3-dioxygenase inhibitors. J Med Chem. 2006 Jan 26;49(2):684-92. | ||||
REF 2 | Indoleamine 2,3-dioxygenase inhibitors from the Northeastern Pacific Marine Hydroid Garveia annulata. J Nat Prod. 2006 Oct;69(10):1496-9. | ||||
REF 3 | Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors. J Med Chem. 2008 Mar 27;51(6):1706-18. | ||||
REF 4 | Synthesis of indoleamine 2,3-dioxygenase inhibitory analogues of the sponge alkaloid exiguamine A. J Med Chem. 2008 May 8;51(9):2634-7. | ||||
REF 5 | Structure based development of phenylimidazole-derived inhibitors of indoleamine 2,3-dioxygenase. J Med Chem. 2008 Aug 28;51(16):4968-77. | ||||
REF 6 | Biomimetic synthesis of the IDO inhibitors exiguamine A and B. Nat Chem Biol. 2008 Sep;4(9):535-7. | ||||
REF 7 | Discovery of potent competitive inhibitors of indoleamine 2,3-dioxygenase with in vivo pharmacodynamic activity and efficacy in a mouse melanoma mo... J Med Chem. 2009 Dec 10;52(23):7364-7. | ||||
REF 8 | Rational design of indoleamine 2,3-dioxygenase inhibitors. J Med Chem. 2010 Feb 11;53(3):1172-89. | ||||
REF 9 | S-benzylisothiourea derivatives as small-molecule inhibitors of indoleamine-2,3-dioxygenase. Bioorg Med Chem Lett. 2010 Sep 1;20(17):5126-9. | ||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.